Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aqua-Yield is a private agricultural nanotechnology company that develops commercial nanoliquid products designed to improve uptake and performance of liquid fertilizers and crop protection inputs. Founded in 2014 and based in Sandy, Utah, the company markets a portfolio of crop nutrition, adjuvant, and coating products including NanoPro, NanoN, NanoCS, NanoPhos, NanoK, NanoStress, NanoCalSi, NanoPack, NanoZn, and NanoCote. Its core platform uses nanoparticle-based delivery technology to enhance plant absorption, improve input efficiency, and reduce fertilizer and pesticide usage. Aqua-Yield is not a life science, biotech, pharma, or healthcare company in the therapeutic sense; it operates in agtech with commercially available products for growers and turf-management users.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aqua-Yield.